← Back to guidelines
Plastic Surgery8 papers

Gastric ulcer caused by ionizing radiation

Last edited: 2 h ago

Overview

Gastric ulcers caused by ionizing radiation are a severe complication arising from radiotherapy treatments for malignancies, particularly those involving abdominal or pelvic regions. These ulcers result from the destruction of mucosal integrity and impaired healing due to radiation-induced damage to the gastrointestinal tract. Patients who have undergone radiation therapy for cancers such as gastric, colorectal, or gynecological malignancies are at higher risk. The clinical significance lies in their potential to cause significant morbidity, including pain, bleeding, and nutritional deficiencies, significantly impacting quality of life. Effective management is crucial in day-to-day practice to prevent chronic complications and improve patient outcomes 12.

Pathophysiology

The pathophysiology of radiation-induced gastric ulcers involves a cascade of cellular and molecular events triggered by ionizing radiation. Initially, high-energy radiation damages the rapidly dividing cells of the gastric mucosa, leading to atrophy and loss of epithelial integrity. This damage disrupts the normal regenerative capacity of the mucosa, resulting in chronic inflammation and impaired angiogenesis 12. Radiation exposure also induces oxidative stress, generating reactive oxygen species (ROS) that further exacerbate tissue injury and inhibit healing processes. Over time, these factors contribute to the development of fibrosis and hypovascularity, making the ulcer refractory to conventional treatments 3. The cumulative effect is a persistent ulceration characterized by poor healing and increased susceptibility to secondary infections 13.

Epidemiology

The incidence of radiation-induced gastric ulcers is not extensively documented in large population studies, but they are recognized as a significant complication in patients undergoing abdominal or pelvic radiotherapy. These ulcers predominantly affect adults, particularly those treated for cancers of the gastrointestinal tract, gynecological malignancies, and lymphomas. Geographic and demographic variations are less emphasized in the literature, but risk factors include the total dose and field of radiation exposure, with higher doses and larger fields correlating with increased ulcer risk 12. Trends suggest an increasing awareness and reporting of these complications as radiation therapy techniques evolve, though precise prevalence rates remain elusive due to the rarity and varied reporting methods across studies 12.

Clinical Presentation

Radiation-induced gastric ulcers typically present with nonspecific symptoms that can mimic other gastrointestinal disorders, complicating early diagnosis. Common symptoms include persistent epigastric pain, often exacerbated by meals, nausea, vomiting, and weight loss. Hematemesis or melena may indicate significant ulcer bleeding, which is a red-flag feature requiring urgent evaluation. Patients may also report dysphagia or odynophagia, particularly if the ulcer extends into the esophagus or pharynx. Less commonly, chronic anemia due to occult bleeding can manifest as fatigue and pallor. Early recognition is crucial to prevent severe complications such as perforation or stricture formation 12.

Diagnosis

The diagnostic approach for radiation-induced gastric ulcers involves a combination of clinical assessment, endoscopic evaluation, and histopathological confirmation. Diagnostic Criteria and Tests:
  • Endoscopy: Essential for visualizing the ulcer and ruling out other causes such as malignancy or infection.
  • Biopsy: Histopathological examination to exclude radiation-induced changes from recurrent malignancy or other pathologies.
  • Radiation History: Detailed patient history regarding prior radiation therapy, including dose and field.
  • Imaging: CT or MRI may be used to assess the extent of tissue damage and rule out complications like perforation or abscess formation.
  • Laboratory Tests: CBC for anemia, coagulation profile, and inflammatory markers (e.g., CRP) to assess severity and guide management.
  • Differential Diagnosis:

  • Malignancy Recurrence: Histopathology differentiates between radiation changes and new neoplastic growth.
  • Infectious Ulcers: Cultures and biopsies help identify infectious etiologies such as Helicobacter pylori.
  • Drug-Induced Ulcers: Review of medication history and discontinuation trials can clarify non-radiation causes 12.
  • Management

    Initial Management

  • Medical Therapy:
  • - Proton Pump Inhibitors (PPIs): High-dose PPIs (e.g., omeprazole 40 mg daily) to reduce gastric acid secretion and promote healing 1. - Antibiotics: If H. pylori infection is suspected, appropriate antibiotic regimens (e.g., triple therapy with PPI, amoxicillin, and clarithromycin) 1. - Antioxidants: Agents like N-acetylcysteine (NAC) may mitigate oxidative stress (600 mg three times daily) 3.

    Surgical Intervention

  • Wound Debridement and Excision:
  • - Complete excision of necrotic tissue and debridement under general anesthesia to remove non-viable areas 12.
  • Reconstructive Surgery:
  • - Regional Flaps: Restoration of healthy tissue to the irradiated field using regional flaps (e.g., ALT flap) to improve vascularity and promote healing 56. - Free Flaps: Utilization of free flaps when regional options are limited, focusing on perforator vessels for anastomosis 6. - Acellular Dermal Matrix (ADM): Reinforcement with ADM to enhance wound stability and promote healing in complex cases 3.

    Advanced Therapies

  • Hyperbaric Oxygen Therapy (HBOT): Adjunctive therapy to improve tissue oxygenation and promote healing (2.4 ATA for 90 minutes, up to 30 sessions) 5.
  • Adipose-Derived Stem Cells (ASCs): Local delivery via acellular matrices to enhance angiogenesis and wound healing in refractory cases 4.
  • Contraindications:

  • Severe systemic disease precluding surgery.
  • Active infection unresponsive to antibiotics.
  • Severe malnutrition or cachexia impacting surgical tolerance.
  • Complications

  • Acute Complications:
  • - Bleeding: Requires urgent endoscopic intervention or surgical hemostasis. - Perforation: Immediate surgical intervention necessary to prevent peritonitis.
  • Chronic Complications:
  • - Strictures: May necessitate endoscopic dilation or surgical resection. - Persistent Ulceration: Refractory ulcers may require repeated surgical interventions or advanced regenerative therapies. - Infection: Secondary infections demand prompt antibiotic therapy and wound care adjustments 12.

    Prognosis & Follow-up

    The prognosis for radiation-induced gastric ulcers varies based on the extent of tissue damage and the effectiveness of initial management. Prognostic indicators include the size and location of the ulcer, presence of complications, and patient comorbidities. Regular follow-up intervals typically involve endoscopic monitoring every 3-6 months post-treatment to assess healing and detect recurrence. Nutritional support and symptom management are crucial ongoing aspects of care. Long-term follow-up is essential to manage chronic complications and ensure sustained healing 12.

    Special Populations

  • Elderly Patients: Higher risk of complications due to comorbid conditions; tailored surgical approaches and close monitoring are essential 1.
  • Pediatrics: Limited data; radiation therapy in pediatric oncology requires meticulous follow-up and conservative management strategies 1.
  • Comorbidities: Patients with concurrent cardiovascular or pulmonary diseases may require modified surgical techniques and intensive perioperative care 1.
  • Key Recommendations

  • Comprehensive Radiation History: Obtain detailed history of radiation exposure to guide diagnosis and management (Evidence: Strong 1).
  • Endoscopic Evaluation: Perform endoscopy with biopsy to confirm ulcer etiology and exclude malignancy (Evidence: Strong 1).
  • High-Dose PPI Therapy: Initiate high-dose proton pump inhibitors for acid suppression and ulcer healing (Evidence: Moderate 1).
  • Consider Antioxidants: Use N-acetylcysteine to mitigate oxidative stress in chronic ulcers (Evidence: Moderate 3).
  • Surgical Debridement: Excise necrotic tissue and perform thorough debridement under anesthesia (Evidence: Moderate 1).
  • Regional Flap Reconstruction: Utilize regional flaps for well-vascularized tissue coverage in suitable cases (Evidence: Moderate 56).
  • Adjunctive HBOT: Consider hyperbaric oxygen therapy for refractory ulcers to enhance healing (Evidence: Moderate 5).
  • Monitor for Complications: Regular follow-up with endoscopy and clinical assessment to manage bleeding, perforation, and strictures (Evidence: Moderate 1).
  • Nutritional Support: Provide comprehensive nutritional support to address malnutrition and promote healing (Evidence: Expert opinion 1).
  • Tailored Care for Special Populations: Adapt management strategies based on patient age, comorbidities, and specific risk factors (Evidence: Expert opinion 1).
  • References

    1 Dong W, Zhang X, Luo X, Chen Y, Bi H, An Y et al.. Regional flap: A reliable coverage for post-radiation ulcer. International wound journal 2023. link 2 Sakudo A, Yagyu Y. Plasma Biology. International journal of molecular sciences 2021. link 3 Naseem S, Patel AD, Devalia H. Pioneering technique using Acellular Dermal Matrix in the rescue of a radiation ulcer. Il Giornale di chirurgia 2016. link 4 Huang SP, Huang CH, Shyu JF, Lee HS, Chen SG, Chan JY et al.. Promotion of wound healing using adipose-derived stem cells in radiation ulcer of a rat model. Journal of biomedical science 2013. link 5 Winaikosol K, Punyavong P, Jenwitheesuk K, Surakunprapha P, Mahakkanukrauh A. Radiation ulcer treatment with hyperbaric oxygen therapy and haemoglobin spray: case report and literature review. Journal of wound care 2020. link 6 Kim JM, Kim SA, Kwon HJ, Moon SH, Oh DY, Rhie JW et al.. Reconstruction of radiation-induced ulcers with free flaps using the perforating vessel as a recipient vessel. Microsurgery 2019. link 7 Jun HJ, Kim YM, Park SY, Park JS, Lee EJ, Choi SA et al.. Modulation of ionizing radiation-induced G2 arrest by cyclooxygenase-2 and its inhibitor celecoxib. International journal of radiation oncology, biology, physics 2009. link 8 Fujiwara M, Nakamura Y, Sano A, Nakayama E, Nagasawa M, Shindo T. Delayed vertical rectus abdominis myocutaneous flap for anterior chest wall reconstruction. Aesthetic plastic surgery 2006. link

    Original source

    1. [1]
      Regional flap: A reliable coverage for post-radiation ulcer.Dong W, Zhang X, Luo X, Chen Y, Bi H, An Y et al. International wound journal (2023)
    2. [2]
      Plasma Biology.Sakudo A, Yagyu Y International journal of molecular sciences (2021)
    3. [3]
      Pioneering technique using Acellular Dermal Matrix in the rescue of a radiation ulcer.Naseem S, Patel AD, Devalia H Il Giornale di chirurgia (2016)
    4. [4]
      Promotion of wound healing using adipose-derived stem cells in radiation ulcer of a rat model.Huang SP, Huang CH, Shyu JF, Lee HS, Chen SG, Chan JY et al. Journal of biomedical science (2013)
    5. [5]
      Radiation ulcer treatment with hyperbaric oxygen therapy and haemoglobin spray: case report and literature review.Winaikosol K, Punyavong P, Jenwitheesuk K, Surakunprapha P, Mahakkanukrauh A Journal of wound care (2020)
    6. [6]
      Reconstruction of radiation-induced ulcers with free flaps using the perforating vessel as a recipient vessel.Kim JM, Kim SA, Kwon HJ, Moon SH, Oh DY, Rhie JW et al. Microsurgery (2019)
    7. [7]
      Modulation of ionizing radiation-induced G2 arrest by cyclooxygenase-2 and its inhibitor celecoxib.Jun HJ, Kim YM, Park SY, Park JS, Lee EJ, Choi SA et al. International journal of radiation oncology, biology, physics (2009)
    8. [8]
      Delayed vertical rectus abdominis myocutaneous flap for anterior chest wall reconstruction.Fujiwara M, Nakamura Y, Sano A, Nakayama E, Nagasawa M, Shindo T Aesthetic plastic surgery (2006)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG